Ironwood Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.84M Buy
19,436
+1,063
+6% +$379K 0.99% 28
2025
Q4
$6.01M Buy
18,373
+2,439
+15% +$774K 0.84% 35
2025
Q3
$4.5M Buy
15,934
+2,107
+15% +$611K 0.66% 45
2025
Q2
$3.86M Buy
13,827
+8,497
+159% +$2.41M 0.6% 47
2025
Q1
$1.66M Buy
5,330
+188
+4% +$55.5K 0.29% 86
2024
Q4
$1.34M Buy
5,142
+358
+7% +$106K 0.23% 98
2024
Q3
$1.54M Buy
4,784
+170
+4% +$55.6K 0.26% 93
2024
Q2
$1.44M Buy
4,614
+44
+1% +$12.9K 0.26% 92
2024
Q1
$1.3M Buy
4,570
+243
+6% +$71.1K 0.23% 99
2023
Q4
$1.25M Sell
4,327
-107
-2% -$29.2K 0.23% 101
2023
Q3
$1.19M Buy
4,434
+304
+7% +$75.9K 0.25% 93
2023
Q2
$917K Buy
4,130
+166
+4% +$38.5K 0.21% 97
2023
Q1
$958K Buy
3,964
+283
+8% +$69.5K 0.23% 98
2022
Q4
$967K Buy
3,681
+76
+2% +$20.4K 0.23% 97
2022
Q3
$812K Buy
3,605
+873
+32% +$212K 0.23% 94
2022
Q2
$664K Buy
2,732
+669
+32% +$164K 0.19% 103
2022
Q1
$499K Buy
2,063
+643
+45% +$148K 0.12% 127
2021
Q4
$319K Sell
1,420
-75
-5% -$15.8K 0.07% 158
2021
Q3
$317K Buy
1,495
+11
+0.7% +$2.53K 0.08% 151
2021
Q2
$361K Buy
1,484
+6
+0.4% +$1.48K 0.1% 145
2021
Q1
$367K Sell
1,478
-230
-13% -$54.9K 0.11% 138
2020
Q4
$392K Sell
1,708
-8
-0.5% -$1.84K 0.09% 154
2020
Q3
$436K Buy
1,716
+16
+0.9% +$3.96K 0.12% 125
2020
Q2
$401K Buy
1,700
+468
+38% +$107K 0.12% 123
2020
Q1
$249K Buy
1,232
+83
+7% +$18.1K 0.1% 139
2019
Q4
$277K Buy
+1,149
New +$253K 0.09% 146

Other funds holding AMGN

Ironwood Investment Counsel's AMGN Position: Q1 2026 in Review

Ironwood Investment Counsel increased its Amgen (AMGN) stake by 5.8% in Q1 2026, buying an estimated $379K and bringing the position to 19,436 shares worth $6.84M. The position accounts for 0.99% of the portfolio, ranked #28.

Ironwood Investment Counsel first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ironwood Investment Counsel held 19,436 shares of Amgen worth $6.84M as of Q1 2026.
  • Ironwood Investment Counsel bought 1,063 Amgen shares in Q1 2026, an estimated $379K.
  • Amgen made up 0.99% of Ironwood Investment Counsel's portfolio in Q1 2026, its #28 holding.
  • Ironwood Investment Counsel first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ironwood Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.